Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 849M 733M 689M 627M 1.18B 81.21B 1.2B 8.08B 3.16B 40.67B 3.19B 3.12B 135B P/E 2026 *
-18.5x
P/E 2027 * -24x
Enterprise Value 898M 776M 729M 663M 1.25B 85.87B 1.27B 8.54B 3.34B 43B 3.37B 3.3B 143B EV / Sales 2026 *
4.24x
EV / Sales 2027 * 3.76x
Free-Float
41.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.38%
1 week-8.51%
Current month-13.24%
1 month-19.03%
3 months+37.35%
6 months+92.57%
Current year+75.38%
1 week 5.55
Extreme 5.55
6.35
1 month 5.41
Extreme 5.41
7.44
Current year 2.8
Extreme 2.8
7.44
1 year 2.28
Extreme 2.28
7.44
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
8/10/26 Tax

Chief Executive Officer

-29,250 0.0198%
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
Change 5-day change 1-year change 3-year change Capi.($)
-1.38%-8.51%+118.39%-45.09% 849M
+1.14%-0.76%+89.72%+293.32% 3.95B
-3.17%-12.64%+36.50%+64.80% 3.32B
+7.06%+10.09%+173.73%-7.06% 3.16B
-4.35%-2.93%+282.77%+369.15% 2.34B
-3.10%+1.70%-21.24%-25.97% 2.31B
-0.43%+3.68%+9.37% - 1.3B
+0.78%+11.25%+15.23%+49.19% 1.04B
+29.91%+22.82%-6.81%+358.96% 616M
-0.20%+6.38%-34.43%+0.16% 566M
Average +2.63%+1.22%+66.32%+117.50% 1.95B
Weighted average by Cap. +0.84%-0.48%+89.60%+131.67%

Financials

2026 *2027 *
Net sales 212M 183M 172M 156M 294M 20.23B 298M 2.01B 787M 10.13B 794M 777M 33.67B 226M 195M 183M 167M 313M 21.58B 318M 2.15B 839M 10.81B 848M 829M 35.92B
Net income -48.85M -42.19M -39.65M -36.06M -67.79M -4.67B -68.91M -465M -182M -2.34B -183M -179M -7.77B -33.6M -29.02M -27.27M -24.8M -46.62M -3.21B -47.39M -319M -125M -1.61B -126M -123M -5.35B
Net Debt 48.8M 42.15M 39.61M 36.02M 67.72M 4.67B 68.84M 464M 181M 2.34B 183M 179M 7.77B -385K -333K -313K -284K -535K -36.84M -543K -3.66M -1.43M -18.45M -1.45M -1.42M -61.3M
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-08-14 US$5.700 -1.38% 2,378,077
26-08-13 US$5.780 0.00% 1,407,285
26-08-12 US$5.780 -0.52% 1,739,327
26-08-11 US$5.810 -4.28% 2,424,129
26-08-10 US$6.070 -2.57% 2,242,949
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
5.700USD
Average target price
7.300USD
Spread / Average Target
+28.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock